Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | GLUD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | RP11-463D19.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | LRRC37A2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | FLII | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | SLC25A29 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ITGAL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | KCNT2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | PDPK1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |